Smarter CQV starts early. Jay Tarter, Josh Morton, and Tulsa Scott share how risk-based planning and continuous testing keep healthcare and pharma projects compliant and on track.
Contributors
Jay Tarter

Jay Tarter

Jay Tarter specializes in regulatory compliance for pharmaceutical manufacturing and packaging companies. With extensive experience in drug and medical device manufacturing, Jay helps clients build quality into their equipment systems, processes, and test methods to meet FDA requirements. His work is instrumental in preparing clients for FDA inspections, as the documentation he produces serves as evidence of quality assurance during regulatory audits. Jay serves as an Associate Vice President and Validation Department Manager at Salas O’Brien. Contact him at [email protected].

All Posts

Josh Morton

Josh Morton

Josh Morton brings over 25 years of experience spanning research, product/process development, clinical, and commercial cGMP manufacturing across small biotech and large pharmaceutical environments. He holds a Master of Science in Biotechnology from Johns Hopkins University. Josh serves as a Senior Process Engineer at Salas O’Brien, where he supports pharmaceutical facility design, process development, equipment design and installation, and qualification. Contact him at [email protected]

All Posts

Tulsa Scott

Tulsa Scott

Tulsa Scott has over 35 years of experience in engineering, commissioning, qualification, and validation. Starting his career in Naval Nuclear Power, he has spent the last 25+ years in the biotech and pharmaceutical industry. He holds a Bachelor’s and Master’s degree in Electrical Engineering from Rensselaer Polytechnic Institute. Tulsa currently serves as the Director of CQV Services for Salas O’Brien, overseeing the expansion and delivery of those services to the North American market. Contact him at [email protected].

All Posts